Ethambutol-induced optic neuropathy

3Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Purpose. A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months. Methods. In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electro-physiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts). Conclusion. Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an ir-reversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists’ surgeries.

Cite

CITATION STYLE

APA

Kyncl, M., Fus, M., & Lestak, J. (2023). Ethambutol-induced optic neuropathy. Biomedical Papers, 167(3), 288–293. https://doi.org/10.5507/bp.2022.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free